Bridging the Sciences: Zika Virus

Meeting Overview

On behalf of Raymond Schinazi, PhD, DSc; José Esparza, MD, PhD; and Mauro Teixeira, MD, PhD, course directors and co-chairs, we are pleased to invite you to Bridging the Sciences: Zika Virus, to be held in Atlanta, Georgia, on May 1 – 3, 2016.

This meeting will facilitate interactions and collaboration between Brazilian scientists and their international colleagues, and will feature scientific sessions geared toward fundamental understanding of Zika biology and practical considerations for management of the infection. Participants in this activity will be updated on key features of Zika epidemiology, pathophysiology, and virology, as well as emerging preventive and therapeutic strategies. These updates on basic and clinical research will be presented in a practical and interactive format that facilitates discussion.

Organizing Committee

Course Directors and Co-Chairs

Raymond F. Schinazi, PhD, DSc, Emory University, Global Virus Network, United States
José Esparza, MD, PhD, President, Global Virus Network, United States
Mauro Teixeira, MD, PhD, Universidade Federal de Minas Gerais, Brazil

Scientific Advisory Board:

Robert Gallo, MD, Institute of Human Virology, University of Maryland School of Medicine, Global Virus Network, United States
Glaucius Oliva, PhD, University of São Paulo, Brazil
Mario Stevenson, PhD, University of Miami, Miller School of Medicine, Global Virus Network, United States
David Watkins, PhD, University of Miami, Miller School of Medicine, Global Virus Network, United States
Scott Weaver, MS, PhD, University of Texas Medical Branch, Galveston Laboratory, Global Virus Network , United States

Local Organizing Committee:

Rafi Ahmed, PhD, Emory University, United States
Leda Bassit, PhD, Emory University, United States
Rana Chakraborty, MD, Emory University, United States
Carlos del Rio, MD, Emory University, United States
Christina Gavegnano, PhD, Emory University, United States
Mark Mulligan, MD, Emory University, United States
Guido Silvestri, MD, Emory University, United States
Paul Spearman, MD, Emory University, United States
Mehul Suthar, PhD, Emory Vaccine Center, United States

Administration:

Ann Findley, Emory University, United States
Kelly Johnson, MBA, Emory University, United States
PLATO Foundation and Informed Horizons, LLC

Topics of Discussion

  • Epidemiology and pathophysiology of Zika virus, including recent findings from the outbreak
  • Insights into diagnosis of Zika virus
  • Models for studying Zika virus
  • Current approaches to control spread
  • Emerging antiviral agents directed at Zika virus
  • Recent findings in vaccine development

Target Audience

This program is designed to meet the educational needs of immunologists, embryologists, epidemiologists, obstetricians, virologists, nurses, and other professionals involved in the study and management of Zika virus infection.

Learning Objectives

After successful completion of this educational activity, participants should be able to:

  • Describe the current understanding of Zika virus epidemiology, manifestation, and pathophysiology
  • Identify current and emerging strategies to minimize spread and impact of Zika virus infection
  • Assess the preliminary findings from ongoing clinical trials investigating antiviral agents and vaccines for ZIka virus

Registration Information and Fees

The organizing committee strongly suggests that you register early to ensure your attendance, as registration will close when the capacity of the venue is reached.

Attendee Registration Fee

Registration fee includes the following:

  • Entrance into all scientific sessions
  • Abstract book and final program
  • Welcome reception following the opening session on Sunday
  • Continental breakfast, refreshment breaks, lunch, and closing cocktail hour on Monday
  • Accommodations, if applicable, at the Emory Conference Center Hotel (limited space available)

Regular Registration (extended through Friday, April 22)

Conference only Conference and
1 night hotel
Conference and
2 nights hotel
Attendees $460 $650 $840
Students/Fellows $360 $550 $740
Industry $560 $750 $940

Late Registration (after Friday, April 22)

Conference only Conference and
1 night hotel
Conference and
2 nights hotel
Attendees $560 $750 $940
Students/Fellows $460 $650 $840
Industry $660 $850 $1040

Accommodations will be reserved on a first come, first served basis at the conference venue.

Emory Conference Center Hotel
1615 Clifton Road NE
Atlanta, Georgia 30329
Main Number: +1 404.712.6000

For additional information contact Jaye Harden, or 678.892.1353.

Cancellation Policies

Conference Fees Only: Please note that cancellation of registrations received on or before April 18, 2016, will incur a $75 administration fee. Cancellation of registrations received after April 18, 2016, and on or before April 28, 2016, will incur a fee equivalent to 50% of the registration payment. No refund of the registration payment will be issued for cancellations received after April 28, 2016.

Hotel Room Reservations: Hotel rooms cancelled prior to April 10, 2016, are fully refundable. Any cancellations on or after April 10 will not be refunded unless the conference is able to resell the room. Every effort will be made, but this cannot be guaranteed.

Faculty & Agenda

Plenary Speakers

  • José Esparza, MD, PhD
    Global Virus Network
    Baltimore, Maryland, United States
  • Mauro Martins Teixeira, PhD
    Universidade Federal de Minas Gerais
    Belo Horizonte, Brazil
  • Maria Van Kerkhove, PhD
    Pasteur Institute
    Paris, France
  • David Watkins, PhD
    University of Miami
    Miami, Florida, United States
  • Scott Weaver, MS, PhD
    University of Texas Medical Branch
    Galveston, Texas, United States

Confirmed Speakers

  • Bryan Cox, PhD
    Emory University
    Atlanta, Georgia, United States
  • Jorge Kalil, MD, PhD
    Instituto Butantan
    São Paulo, Brazil
  • Emma Mohr, MD
    University of Wisconsin
    Madison, Wisconsin, United States
  • Glaucius Oliva, PhD
    University of São Paulo Institute of Physics of São Carlos
    São Paulo, Brazil
  • Rosana Richtmann, MD, PhD
    Emilio Ribas Institute of Infectious Diseases
    São Paulo, Brazil
  • Mehul Suthar, PhD
    Emory Vaccine Center
    Atlanta, Georgia, United States
  • Amilcar Tanuri, MD, PhD
    Universidade Federal de Rio de Janeiro
    Rio de Janeiro, Brazil
  • Timothy Tellinghuisen, PhD
    Scripps Research Institute
    Jupiter, Florida, United States
  • Pedro F. C. Vasconcelos, MD
    Instituto Evandro Chagas
    Ananindeua, Pará, Brazil
  • Gonzalo Vazquez-Prokopec, PhD
    Emory University
    Atlanta, Georgia, United States
  • Paul Root Wolpe, PhD
    Emory University
    Atlanta, Georgia, United States

Other Confirmed Faculty

  • Baek Kim, PhD
    Emory University
    Atlanta, Georgia, United States
  • Suzane Kioko Ono, MD, PhD
    University of São Paulo
    São Paulo, Brazil
  • Carlos del Rio, MD
    Emory University
    Atlanta, Georgia, United States
  • Raymond F. Schinazi, PhD, DSc
    Emory University
    Atlanta, Georgia, United States
  • Mario Stevenson, PhD
    University of Miami
    Miami, Florida, United States
  • Paolo Marinho de Andrade Zanotto, PhD
    University of São Paulo, Institute of Biomedical Sciences
    São Paulo, Brazil

Agenda

Sunday, May 1, 2016
AFTERNOON SESSION

 

Opening Remarks
Raymond F. Schinazi, PhD, DSc

EPIDEMIOLOGY, MANIFESTATIONS, & ETHICS SESSION

Chairs:

Glaucius Oliva, PhD
Raymond F. Schinazi, PhD, DSc

State-of-the-Art Lecture:
Zika in the Broader Context of Other Emerging Viral Epidemics
José Esparza, MD, PhD

Zika Virus Epidemic in Brazil: Present Situation and Perspectives
Pedro F. C. Vasconcelos, MD

Real-Time Experience of Management of Clinical Cases With Zika Infection From Endemic States Seeking Treatment at One of the Largest Infectious Diseases Hospitals in Brazil
Rosana Richtmann, MD, PhD

How Zika Is Challenging Global Health Ethics
Paul Root Wolpe, PhD

Round Table Discussion
All Faculty Above

WELCOME RECEPTION

Monday, May 2, 2016
VIROLOGY, PATHOLOGY, & ANIMAL MODELS SESSION

Chairs:

Suzane Kioko Ono, MD, PhD
Mario Stevenson, PhD

State-of-the-Art Lecture:
Approaches to Manage and Control Zika Virus Infections
Scott Weaver, MS, PhD

Working Toward a Zika Virus Replicon System and Infectious Clone
Timothy Tellinghuisen, PhD

Structural Insights Into Zika Virus Proteins
Glaucius Oliva, PhD

Animal Models for Zika Virus
Emma Mohr, MD

State-of-the-Art Lecture:
Link Between Zika, Guillain-Barré Syndrome, and Microencephaly
Maria Van Kerkhove, PhD

Late Breaker Talks

Zika Virus: Accelerating Development of Medical Countermeasures by Re-purposing Licensed Drugs
Robert Malone, MD, Atheric Pharmaceutical

Zika Virus in an HIV-Infected Cohort in Ghana
Kenneth Sherman, MD, PhD, University of Cincinnati

Development of a Zika Virus Polymerase Assay to Aid in the Identification of a Ribonucleoside Zika Virus Polymerase Inhibitor
Gaofei Lu, PhD, Emory University

Necrotizing Acute Acalculous Cholecystitis and Zika Virus Infection in an Immunocompromised Individual with Gilbert Syndrome
Suzane Kioko Ono, MD, PhD, University of São Paulo

A Novel Cell Based Antiviral Assay for Zika Virus
Raj Kalkeri, MBA, Southern Research

Development of Immunological Countermeasures for Zika Virus
Luke Robinson, Visterra, Inc.

Development of Zika Vaccine
Farshad Guirakhoo, PhD, GeoVax, Inc

ANTIVIRAL AGENTS SESSION

Chairs:

Jorge Kalil, MD, PhD
Baek Kim, PhD

State-of-the-Art Lecture:
Anti-Inflammatory Drugs for Zika Virus and Other Flaviviruses
Mauro Martins Teixeira, PhD

Biological and Virological Properties of Brazilian Zika Virus Isolates
Amilcar Tanuri, MD, PhD

Predicting the Structural Biology of Zika Virus—Challenges and Targets for Intervention
Bryan Cox, PhD

IMMUNOLOGY, DIAGNOSIS, & ECOLOGY SESSION

Chairs:

Scott Weaver, MS, PhD
Paolo Marinho de Andrade Zanotto, PhD

State-of-the-Art Lecture:
Vaccines and Monoclonal Antibody Treatments for Zika
David Watkins, PhD

Strategies to Develop Antibodies and Vaccines to Fight Zika Virus
Jorge Kalil, MD, PhD

Innate Immune Control of Zika Virus Infection
Mehul Suthar, PhD

Using Dengue Virus to Understand the Spatial Dimension of Zika Surveillance, Transmission, and Control
Gonzalo Vazquez-Prokopec, PhD

Round Table Discussion With Expert Panel and Audience
Sex Transmission and Mosquitoes: A New Phenomenon in Arbovirology?

Leaders:

Panel:

Carlos del Rio, MD
José Esparza, MD, PhD
Jorge Kalil, MD, PhD
Glaucius Oliva, PhD
Timothy Tellinghuisen, PhD
Mauro Martins Teixeira, PhD
Maria Van Kerkhove, PhD
Gonzalo Vazquez-Prokopec, PhD
David Watkins, PhD
Scott Weaver, MS, PhD
Paolo Marinho de Andrade Zanotto, PhD

Closing Remarks Raymond Schinazi, PhD, DSc

Happy Hour

Tuesday, May 3, 2016
MORNING SESSION (optional)

 

Public Forum and Press
José Esparza, MD, PhD
Mauro Martins Teixeira, PhD
Glaucius Oliva, PhD
Raymond Schinazi, PhD, DSc
Scott Weaver, MS, PhD

Guidelines for Submitting an Abstract

You are asked to follow these guidelines when submitting an abstract, and upload your abstract during the registration process.

  • Please note that abstract submission is part of the registration process. Therefore, abstract submission cannot be done without registering for meeting attendance.
  • The abstract committee will decide which abstracts will be accepted, and also which abstracts are selected for oral presentations.
  •  Should your abstract not be accepted by the abstract review committee, then you are entitled to have your registration fee refunded. Please send a request for refund to Jaye.Harden@prIMEoncology.org.
  •  At least one of the authors of the accepted abstract MUST attend the meeting and present the abstract.
  • Abstract submission deadline is 11.00 PM US Eastern Time, on Monday, April 18, 2016

Categories:

  • Epidemiology
  • Pathogenesis – human and animal
  • Antiviral agent development
  • Vaccine development
  • Animal models
  • Differential diagnostics
  • Mosquito control

Requirements:

  • Abstracts must contain recent, unpublished information
  • Abstract must be written in English
  • Abstracts will not be edited once submitted
  • Requested filename: <<abstractZika_2016_LAST NAME_FIRST INITIALS of the first author>>
    eg, : <<abstractZika_2016_JOHANSSON_FKT>>
  • The abstract title should be as concise as possible; should appear in bold, lowercase font; and should be centered
  • Main body of text to be left aligned
  • Abstract should be sent as a Microsoft Word document; single‐spaced throughout the abstract; typed in lowercase Arial font size 11
  • List affiliations of author(s) in the abstract as briefly as possible, eg:
    Author(s):
    A. Author, 1,2, B . Author, 1, C. Author, 2
    1. Institution Name, City, (State if USA), Country
    2. Institution Name, City, (State if USA), Country
  • Place an asterisk (*) after the senior author and underline the name of the presenting author. Once accepted, presenting author cannot be substituted without permission from the organizer.
  • There is no maximum word count for the abstract, but the abstract should be concise
  • All accepted abstracts will be presented in an oral format; the presentation should be limited to 6 slides including the title slide; and the talk should be given in under 8 minutes, with a maximum of 2 minutes for questions
  • References, cited with superscripted numbers in the text, should be listed at the end of the text using standard and well accepted formats
  • The use of figures, graphs, and schemes is recommended when they aid in the understanding of the text
  • Please include the full address and contact details of the main author and the presenting author, and indicate whether you are submitting an oral or a poster presentation (can be indicated on online registration form)
  • Use standard, well accepted abbreviations
  • Abstract should contain the following subheads:
    1. Purpose of the study
    2. Methods/summarized description of the project
    3. Results
    4. Conclusions
  • Data presented at other meetings is acceptable, but if the presentation was made at an international meeting of more than 100 attendees, please indicate in the abstract that part or all of the material has also been presented, and the name and date of the meeting

Please contact us at Jaye.Harden@prIMEoncology.org or telephone +1 678.892.1353 if you have any questions.

Exhibitor Information

$2500 Exhibitor Package includes:

  • One draped 6’ table with (2) chairs
  • Registration and name badges for two (2) company representatives to exhibit and attend the educational sessions
  • Breakfast, breaks, lunch, and receptions for two (2) company representatives
  • Post-meeting list of attendees (name, city, state)

Additional representatives may attend for $560 each.

Exhibitor Registration

Online registration is now available. The name and email addresses of both representatives attending are required fields. Payment can be made by check or online by credit card.

PLEASE NOTE: If you choose to pay online via credit card, you will incur a 4.95% processing fee.

For payment by check, please make checks payable to PLATO Foundation
Tax ID # 27-2320951 for the designated amount and send by overnight mail to:

PLATO Foundation
Two Concourse Parkway, Suite 260
Atlanta, GA 30328
Attention: Jaye Harden – Zika Conference

For questions or further information, please contact Jaye Harden, 678.892.1353 or Jaye.Harden@prIMEoncology.org

Shipping to the Venue

If you are shipping materials to the hotel, please number each box in your shipment (eg, Box 1 of 3) and address packages as follows:

Your Name & Company’s Name
c/o Jaye Harden
Emory Conference Center Hotel
1615 Clifton Road NE, Atlanta, GA 30329
ATTN: Zika Virus Conference, May 1-2, 2016